Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Krka d. d
KRKKrka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company also provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising analgesics antimicrobials, antiparasitics, disinfectants, vitamins, and minerals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia. Address: ?marje?ka cesta 6, Novo Mesto, Slovenia, 8501
Analytics
Zielpreis von Wall Street
436.85 PLNKGV
11.3897Dividendenrendite
5.6 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen KRK
Dividenden-Analyse KRK
Dividendenwachstum über 5 Jahre
136 %Kontinuierliches Wachstum
6 JahreAusschüttungsquote 5-Jahres-Durchschnitt
54 %Verlauf der Dividende KRK
Bewertung der Aktie KRK
Finanzen KRK
Ergebnisse | 2019 | Dynamik |